Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2023 Sep 8;46(9):zsad167.
doi: 10.1093/sleep/zsad167.

Does providing feedback and guidance on sleep perceptions using sleep wearables improve insomnia? Findings from "Novel Insomnia Treatment Experiment": a randomized controlled trial

Affiliations
Randomized Controlled Trial

Does providing feedback and guidance on sleep perceptions using sleep wearables improve insomnia? Findings from "Novel Insomnia Treatment Experiment": a randomized controlled trial

Marie-Antoinette Spina et al. Sleep. .

Abstract

Study objectives: Insomnia is a disorder diagnosed based on self-reported sleep complaints. Differences between self-reported and sensor-based sleep parameters (sleep-wake state discrepancy) are common but not well-understood in individuals with insomnia. This two-arm, parallel-group, single-blind, superiority randomized-controlled trial examined whether monitoring sleep using wearable devices and providing support for interpretation of sensor-based sleep data improved insomnia symptoms or impacted sleep-wake state discrepancy.

Methods: A total of 113 (age M = 47.53; SD = 14.37, 64.9% female) individuals with significant insomnia symptoms (Insomnia Severity Index(ISI) ≥10) from the community were randomized 1:1 (permuted block randomization) to receive 5 weeks (1) Intervention (n = 57): feedback about sensor-based sleep (Fitbit and EEG headband) with guidance for data interpretation and ongoing monitoring, and (2) Control (n = 56): sleep education and hygiene. Both groups received one individual session and two check-in calls. The ISI (primary outcome), sleep disturbance (SDis), sleep-related impairment (SRI), depression, and anxiety were assessed at baseline and post-intervention.

Results: In total, 103 (91.2%) participants completed the study. Intention-to-treat multiple regression with multiple imputations showed that after controlling for baseline values, compared to the Control group (n = 51), the Intervention group (n = 52) had lower ISI (p = .011, d = 0.51) and SDis (p = .036, d = 0.42) post-intervention, but differences in SRI, depression, anxiety, and sleep-wake state discrepancy parameters (total sleep time, sleep onset latency, and wake after sleep onset) were not meaningful (P-values >.40).

Conclusions: Providing feedback and guidance about sensor-based sleep parameters reduced insomnia severity and sleep disturbance but did not alter sleep-wake state discrepancy in individuals with insomnia more than sleep hygiene and education. The role of sleep wearable devices among individuals with insomnia requires further research.

Clinical trial registration: The Novel Insomnia Treatment Experiment (NITE): the effectiveness of incorporating appropriate guidance for sleep wearables in users with insomnia. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=378452, Australia New Zealand Clinical Trials Registry: ACTRN12619001636145.

Keywords: Dreem; Fitbit; Insomnia; Sleep; Sleep–wake estimation; Sleep–wake state discrepancy.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1.
Figure 1.
CONSORT diagram for participant flow.
Figure 2.
Figure 2.
Model estimated means and 95% confidence intervals of Insomnia Severity Index (ISI), PROMIS Sleep Disturbance (SD), PROMIS SRI, Dysfunctional Beliefs and Attitudes about Sleep (DBAS), PSA, TST difference (sleep diary minus Fitbit), SOL difference (sleep diary–Dreem), and WASO difference (sleep diary–Dreem) at Baseline and Post-Intervention (Post).

References

    1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5). Washington, DC: American Psychiatric Association Publishing; 2013.
    1. Ancoli-Israel S, Roth T.. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep. 1999;22:S347–S353. - PubMed
    1. Ford DE, Kamerow DB.. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention? JAMA. 1989;262(11):1479–1484. doi: 10.1001/jama.262.11.1479 - DOI - PubMed
    1. Kim K, Uchiyama M, Okawa M, Liu X, Ogihara R.. An epidemiological study of insomnia among the Japanese general population. Sleep. 2000;23(1):41–47. - PubMed
    1. Ohayon MM, Hong S-C, Hong S-C.. Prevalence of insomnia and associated factors in South Korea. J Psychosom Res. 2002;53(1):593–600. doi: 10.1016/s0022-3999(02)00449-x - DOI - PubMed

Publication types